Group 1 - The core viewpoint of the news is that New Industry has experienced a significant stock price increase, with a rise of 5.11% on September 8, reaching a price of 68.30 yuan per share, and a total market capitalization of 53.665 billion yuan [1] - New Industry's stock has seen a cumulative increase of 4.34% over the past three days, indicating positive market sentiment [1] - The company, Shenzhen New Industry Biomedical Engineering Co., Ltd., specializes in the research, development, production, and sales of fully automated chemiluminescence immunoassay instruments and related reagents, with reagent sales accounting for 69.62% of its revenue [1] Group 2 - From the perspective of fund holdings, Huian Fund has a significant position in New Industry, with its Huian Asset Rotation Mixed A Fund (005360) being the fourth largest holding, representing 3.98% of the fund's net value [2] - The fund reduced its holdings by 19,100 shares in the second quarter, now holding 10,800 shares, and has realized a floating profit of approximately 35,900 yuan as of the latest report [2] - The fund has shown a year-to-date return of 11.91% and a one-year return of 21.82%, indicating strong performance relative to its peers [2]
新产业股价涨5.11%,汇安基金旗下1只基金重仓,持有1.08万股浮盈赚取3.59万元